Summary of Key Information:
Reporting Period: Quarter ended June 30, 2026 (Q1 FY27)
Nature of Filing: Outcome of Board Meeting - Unaudited Financial Results
Audit Opinion:
Unmodified opinion (clean) issued by M/s. Rajendra & Co., Chartered Accountants
Key Financial Highlights [₹ in lakhs]:
Standalone Results:
| Metric | Quarter Ended June 30, 2026 | Quarter Ended June 30, 2025 | Quarter Ended March 31, 2026 |
| Revenue from Operations | 15,582 | 13,925 | 16,556 |
| Total Income | 15,582 | 13,925 | 16,556 |
| Total Expenses | 13,706 | 13,755 | 15,360 |
| Profit before tax | 1,876 | 170 | 1,196 |
| Tax Expense | 474 | 51 | 310 |
| Net Profit | 1,402 | 119 | 886 |
| EPS (₹) (Basic and Diluted) | 13.57 | 1.15 | 8.58 |
| Other Comprehensive Income | 47 | 73 | (37) |
| Total Comprehensive Income | 1,449 | 192 | 849 |
| Paid-up Equity Share Capital | 1,033 | 1,033 | 1,033 |
Performance Analysis: Q1 FY26 net profit of ₹14.02 crore shows significant improvement compared to ₹1.19 crore in Q1 FY25 (1,078% increase) and ₹8.86 crore in Q4 FY26 (58% increase).
Consolidated Results:
Not Specified
Segment-wise Performance:
The Company is engaged in the business of manufacturing of Chemicals, which is the only reportable operating segment as per Ind AS 108.
Corporate Actions:
Not Specified
Other Significant Information:
Exceptional Items: During FY26, the company recognized an incremental employee benefit obligation of ₹46 lakhs pertaining to past services rendered as an Exceptional Item due to implementation of New Labour Codes.
Temporary Closure Impact: The temporary closure at Tarapur unit has not had, and is not expected to have, any material impact on the Company's operations or financial position.